Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain ...
PRO-XTEN dual masking aims to keep the engager inactive in circulation, activate within tumor protease-rich microenvironments ...
In the intent-to-treat population, the median OS was 13.2 months with daraxonrasib vs 6.7 months for chemotherapy, ...
A newly identified interaction between ovarian cancer cells and surrounding abdominal cells helps explain the cancer’s ...
AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have ...
Apoptosis is a process in which cells die off, intentionally. This programmed cell death pathway helps eliminate billions of cells every day, most of which are blood or gut cells, so they can be ...
A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results